Penny S. Toren
Nessuna posizione attualmente
Storia della carriera di Penny S. Toren
Precedenti posizioni note di Penny S. Toren
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GRI BIOPAR | Consigliere Generale | 01/04/2018 | 19/04/2022 |
Formazione di Penny S. Toren
| Florida Atlantic University | Undergraduate Degree |
| New York Medical College | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| General Counsel | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Penny S. Toren
- Esperienza
